Sponsored & Endowed Lectures

Novartis Lecture

The Novartis Lecture is sponsored by the Novartis Institutes for BioMedical Research (NIBR) to feature the most innovative scientists working in synthetic organic chemistry today.

2012-2013 Speaker

Prof. Uttam Tambar
Department of Biochemistry
University of Texas Southwestern Medical Center

Catalytic Asymmetric Molecular Rearrangements
December 3, 2012

---

Lambert Lecture

The Lambert Lecture is supported by an endowment established by alumnus Benjamin Lambert , who earned his bachelor’s degree in chemistry at Boston University (CAS ’55). After graduating from law school, he went on to pursue a distinguished career as a patent attorney with such major pharmaceutical companies as Merck and Johnhson & Johnson. Each year, the Lambert Lecture addresses different topics in organic chemistry, the field of Lambert’s undergraduate and graduate studies, and features some of the most distinguished and creative scientists working in the field of organic chemistry today.

2011-2012 Speaker

Professor Larry E. Overman
Department of Chemistry
University of California, Irvine

Recent Studies in Stereoselective Synthesis of Bioactive Heterocycles
April 27. 2012

---

Organic Syntheses, Inc. Lecture

The lecture is sponsored by the journal, Organic Syntheses, to feature innovative scientists working in synthetic organic chemistry today.

2009-2010 Speaker

Professor Daniel Romo
Texas A&M University

Bioactive Natural Products as Enduring Forums for Chemical Synthesis, Cellular Probe Discovery, and Identification of Therapeutic Targets
November 9, 2009

“Natural products continue to be versatile forums for synthetic strategy development, for identification of probes for basic cell biology, and lead discovery for human disease intervention. In this regard, the marine sponge isolate, pateamine A (PatA) from Mycale sp., has allowed us to explore each of these facets of natural products chemistry.

In more recent chemical synthesis efforts, we have developed novel strategies to gymnodimine, the seemingly simplest member of a class of spirocyclic imine-containing toxins for use as an immunogen for development of an ELISA assay for ocean toxin monitoring. Recent advances in our development of the nucleophile catalyzed aldol-lactonization (NCAL) process leading to bicyclic b-lactones has enabled a concise, A1,3-strain enabled, enantioselective synthesis of the potent proteasome inhibitor, salinosporamide and designed derivatives.”